In PCa, increased stromal MIC-1/GDF15 is associated with better patient outcomes, especially in those with low-grade localized prostate tumors (Gleason sum score of 6 or less) [28], suggesting that its increased local availability is beneficial. This evidence concerns the gene GDF15 and posterior cortical atrophy.